Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Epithelial ovarian cancer has the highest mortality rate among gynecological cancers. Altered glycosylation is associated with oncogenic transformation producing tumor‐associated carbohydrate antigens. We investigated the potential of natural occurring antiglycan antibodies in the diagnosis of ovarian cancer by using printed glycan array. Antiglycan antibodies bound to 203 chemically synthesized printed glycans were detected via biotin‐streptavidin fluorescence system in serum of women with normal operative findings (healthy controls; n = 24) and nonmucinous borderline or ovarian cancer of various FIGO stages (n = 33). Data were validated measuring blood group associated di‐, tri and tetrasaccharide antigens on known ABO blood groups. Antiglycan antibodies demonstrated high reproducibility (rc > 0.9). Cluster analysis identified repetitive patterns of specific core carbohydrate structures: 11 N‐linked glycans, 3 O‐linked glycans and 2 glycosphingolipids. Biomarker detection revealed 24 glycans including P 1 (Galα1–4Galβ1–4GlcNAcβ; p < 0.001) significantly discriminating between (low‐) malignant tumors and healthy controls. Comparable sensitivity and specificity with tumor marker CA125 was achieved by a panel of multivariate selected and linear combined antiglycan antibody signals (79.2 and 84.8%, respectively). Our findings demonstrate the potential of glycan arrays in the development of a new generation of biomarkers for ovarian cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A concordance correlation coefficient to evaluate reproducibility.
Lin, L. I.-K. (1989) · Biometrics · doi:10.2307/2532051 · Cited by 8,785
Cited by
Cell surface protein glycosylation in cancer
Christiansen, M. N., Chik, J., Lee, L., Anugraham, M., Abrahams, J. L., & Packer, N. H. (2014) · PROTEOMICS · doi:10.1002/pmic.201300387 · Cited by 518
Emergence and significance of carbohydrate-specific antibodies
Kappler, K., & Hennet, T. (2020) · Genes & Immunity · doi:10.1038/s41435-020-0105-9 · Cited by 118
Competition between Serum IgG, IgM, and IgA Anti-Glycan Antibodies
Muthana, S. M., Xia, L., Campbell, C. T., Zhang, Y., & Gildersleeve, J. C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0119298 · Cited by 53
Metadata
- Authors
- Jacob, F., Goldstein, D. R., Bovin, N. V., Pochechueva, T., Spengler, M., Caduff, R., Fink, D., Vuskovic, M. I., Huflejt, M. E., & Heinzelmann‐Schwarz, V.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2011-04-25
- Volume
- 130
- Issue
- 1
- Pages
- 138-146
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2078404437
- Cited by
- 73
- References
- 1
- FWCI
- 2.35
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. https://app.cochat.ai/papers/10.1002/ijc.26002
- The paper
- Jacob, F., Goldstein, D. R., Bovin, N. V., Pochechueva, T., Spengler, M., Caduff, R., Fink, D., Vuskovic, M. I., Huflejt, M. E., & Heinzelmann‐Schwarz, V. (2012). Serum antiglycan antibody detection of nonmucinous ovarian cancers by using a printed glycan array. International Journal of Cancer. https://doi.org/10.1002/ijc.26002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.